Helen V. Evsyukova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Helen V. Evsyukova has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
Andreas Roessler
Institute of Physiology Medical University of Graz Austria
1 shared publicationAnna Witasp
Divisions of Renal Medicine and Baxter Novum Department of Clinical Science Intervention and Technology Karolinska Institutet Stockholm Sweden
1 shared publicationChrisoula D. Scopa
Department of Pathology University Hospital of Patras Patras Greece
1 shared publicationChristopher Adlbrecht
Division of Cardiology Department of Internal Medicine II Medical University of Vienna Vienna Austria
1 shared publication- Clemens Höbaus
Division of Angiology, Department of Medicine II, Medical University of Vienna, Vienna, Austria
1 shared publication Francesca Santamaria
Department of Translational Medical Sciences Federico II University Naples Italy
1 shared publication
Latest Publications
- Open Access
- 3 July 2013
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 43 (10) , 1097-1110
Research update for articles published in EJCI in 2011
- 3 July 2013
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 43 (10) , 1097-1110
Open AccessResearch update for articles published in EJCI in 2011
- 17 February 2011
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 41 (7) , 781-784
Expression of melatonin in platelets of patients with aspirin-induced asthma
The diffuse neuroimmunoendocrine system (DNIES) is a universal system of response, control and organism protection. Platelets are cells of DNIES producing and storing melatonin which plays an important role in the regulation of physiological processes in the human body, under normal conditions and in pathology. Our previous study has revealed a low basic melatonin production in patients with aspirin-induced asthma (AIA). It has been suggested that low daytime production of melatonin in patients with AIA is attributable to the reduction in its synthesis in platelets in this group of patients. The objective of this study was to investigate this hypothesis. The melatonin expression in platelets has been studied by means of indirect immunofluorescence in nine patients with AIA and 14 healthy subjects. The results of the study have revealed that only 13·1 ± 1·3% of platelets in patients with AIA have shown melatonin-specific luminescence, compared to 97·7 ± 0·6% of platelets in healthy subjects (P < 0·001). No melatonin expression has been observed in the rest of platelets in patients with AIA. No significant difference between the degree of the melatonin luminescence in platelets of the patients with AIA and control group has been found. It can be concluded that the reduced melatonin synthesis in platelets of patients with AIA may determine a low daytime melatonin production and may lead to impairments in platelet receptors and ion channels. This results in disturbances in calcium homoeostasis, which may be a cause of platelet activation and pathological response to exogenous melatonin and acetylsalicylic acid.
- 17 February 2011
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 41 (7) , 781-784
Expression of melatonin in platelets of patients with aspirin-induced asthma
The diffuse neuroimmunoendocrine system (DNIES) is a universal system of response, control and organism protection. Platelets are cells of DNIES producing and storing melatonin which plays an important role in the regulation of physiological processes in the human body, under normal conditions and in pathology. Our previous study has revealed a low basic melatonin production in patients with aspirin-induced asthma (AIA). It has been suggested that low daytime production of melatonin in patients with AIA is attributable to the reduction in its synthesis in platelets in this group of patients. The objective of this study was to investigate this hypothesis. The melatonin expression in platelets has been studied by means of indirect immunofluorescence in nine patients with AIA and 14 healthy subjects. The results of the study have revealed that only 13·1 ± 1·3% of platelets in patients with AIA have shown melatonin-specific luminescence, compared to 97·7 ± 0·6% of platelets in healthy subjects (P < 0·001). No melatonin expression has been observed in the rest of platelets in patients with AIA. No significant difference between the degree of the melatonin luminescence in platelets of the patients with AIA and control group has been found. It can be concluded that the reduced melatonin synthesis in platelets of patients with AIA may determine a low daytime melatonin production and may lead to impairments in platelet receptors and ion channels. This results in disturbances in calcium homoeostasis, which may be a cause of platelet activation and pathological response to exogenous melatonin and acetylsalicylic acid.
- 1 July 2006
- Published by Pleiades Publishing Ltd in Human Physiology
- Vol. 32 (4) , 478-485
APUD cells the human pulmonary neuroendocrine system
Literature data are presented on the anatomy of the diffuse neuroendocrine system (DNES) of the human lungs. The following subjects are discussed: physiological effects of the biologically active substances synthesized, stored, and secreted by the pulmonary neuroendocrine cells; their immunomodulating function; and the role of the DNES in the pathogenesis of bronchial asthma and other bronchopulmonary diseases.
- 1 July 2006
- Published by Pleiades Publishing Ltd in Human Physiology
- Vol. 32 (4) , 478-485
APUD cells the human pulmonary neuroendocrine system
Literature data are presented on the anatomy of the diffuse neuroendocrine system (DNES) of the human lungs. The following subjects are discussed: physiological effects of the biologically active substances synthesized, stored, and secreted by the pulmonary neuroendocrine cells; their immunomodulating function; and the role of the DNES in the pathogenesis of bronchial asthma and other bronchopulmonary diseases.
- 1 June 1999
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 29 (6) , 563-567
The role of melatonin in pathogenesis of aspirin-sensitive asthma
- 1 June 1999
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 29 (6) , 563-567
The role of melatonin in pathogenesis of aspirin-sensitive asthma
- 1 June 1998
- Published by Elsevier in Pathophysiology
- Vol. 5, 258
Melatonin and glucocorticoid homeostasis in patients with aspirin-induced asthma
- 1 June 1998
- Published by Elsevier in Pathophysiology
- Vol. 5, 258
Melatonin and glucocorticoid homeostasis in patients with aspirin-induced asthma